T1	Intervention 324 444	double-blind trial of two groups of patients diltiazem and placebo, 3 to 4 tablets a day (diltiazem 180 to 240 mg daily)
T2	Intervention 446 588	The patients were evaluated after laboratory tests and clinical-ergometric examinations. A coronary arteriography was performed on study entry
